Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.
Author
Alamri, Mubarak ATahir Ul Qamar, Muhammad
Alabbas, Alhumaidi B
Alqahtani, Safar M
Alossaimi, Manal A
Azam, Sikandar
Hashmi, Muhammad Harris
Rajoka, Muhammad Shahid Riaz
Date
2022-10-01Journal
MoleculesType
Article
Metadata
Show full item recordAbstract
The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has stressed the global health system to a significant level, which has not only resulted in high morbidity and mortality but also poses a threat for future pandemics. This situation warrants efforts to develop novel therapeutics to manage SARS-CoV-2 in specific and other emerging viruses in general. This study focuses on SARS-CoV2 RNA-dependent RNA polymerase (RdRp) mutations collected from Saudi Arabia and their impact on protein structure and function. The Saudi SARS-CoV-2 RdRp sequences were compared with the reference Wuhan, China RdRp using a variety of computational and biophysics-based approaches. The results revealed that three mutations-A97V, P323I and Y606C-may affect protein stability, and hence the relationship of protein structure to function. The apo wild RdRp is more dynamically stable with compact secondary structure elements compared to the mutants. Further, the wild type showed stable conformational dynamics and interaction network to remdesivir. The net binding energy of wild-type RdRp with remdesivir is -50.76 kcal/mol, which is more stable than the mutants. The findings of the current study might deliver useful information regarding therapeutic development against the mutant RdRp, which may further furnish our understanding of SARS-CoV-2 biology.Identifier to cite or link to this item
http://hdl.handle.net/10713/19974ae974a485f413a2113503eed53cd6c53
10.3390/molecules27196475
Scopus Count
Related articles
- Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type.
- Authors: Mohammad A, Al-Mulla F, Wei DQ, Abubaker J
- Issue date: 2021 Jun 22
- Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.
- Authors: Dhankhar P, Dalal V, Kumar V
- Issue date: 2021 Dec
- The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
- Authors: Lung J, Lin YS, Yang YH, Chou YL, Shu LH, Cheng YC, Liu HT, Wu CY
- Issue date: 2020 Jun
- Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp).
- Authors: Karthic A, Kesarwani V, Singh RK, Yadav PK, Chaturvedi N, Chauhan P, Yadav BS, Kushwaha SK
- Issue date: 2022 Jan 26
- Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA-dependent RNA polymerase (RdRp) inhibition: an in-silico analysis.
- Authors: Singh S, Sk MF, Sonawane A, Kar P, Sadhukhan S
- Issue date: 2021 Oct